Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.your-feed-science, Vaccination and Immunization, Blood Clots, Disease Rates, Coronavirus (2019-nCoV), Research, Drugs (Pharmaceuticals), Immune System, AstraZeneca PLC, Food and Drug Administration, Johnson & Johnson, Moderna Inc, Pfizer IncRead More
